Tariciotti Leonardo, Fiore Giorgio, Carapella Sara, Remore Luigi Gianmaria, Schisano Luigi, Borsa Stefano, Pluderi Mauro, Canevelli Marco, Marfia Giovanni, Caroli Manuela, Locatelli Marco, Bertani Giulio
Unit of Neurosurgery, Foundation IRCCS Cà Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
Cancers (Basel). 2022 Jun 22;14(13):3065. doi: 10.3390/cancers14133065.
Object: To investigate those parameters affecting early and follow-up functional outcomes in patients undergoing resection of meningiomas and to design a dedicated predictive score, the Milan Bio(metric)-Surgical Score (MBSS) is hereby presented. Methods: Patients undergoing transcranial surgery for intracranial meningiomas were included. The most significant parameters in the regression analyses were implemented in a patient stratification score and were validated by testing its classification consistency with a clinical−radiological grading scale (CRGS), Milan complexity scale (MCS), and Charlson Comorbidity Index (CCI) scores. Results: The ASA score, Frailty index, skull base and posterior cranial fossa locations, a diameter of >25 mm, and the absence of a brain−tumour interface were predictive of early post-operative deterioration and were collected in MBSS Part A (AUC: 0.965; 95%C.I. 0.890−1.022), while the frailty index, posterior cranial fossa location, a diameter of >25 mm, a edema/tumour volume index of >2, dural sinus invasion, DWI hyperintensity, and the absence of a brain−tumour interface were predictive of a long-term unfavourable outcome and were collected in MBSS Part B (AUC: 0.877; 95%C.I. 0.811−0.942). The score was consistent with CRGS, MCS, and CCI. Conclusion: Patients’ multi-domain evaluation and the implementation of frailty indexes might help predict the perioperative complexity of cases; the functional, clinical, and neurological early outcomes; survival; and overall QoL after surgery.
为研究影响脑膜瘤切除患者早期及随访功能预后的参数,并设计一个专门的预测评分系统,特提出米兰生物(计量)-手术评分(MBSS)。方法:纳入接受颅内脑膜瘤经颅手术的患者。回归分析中最显著的参数被纳入患者分层评分,并通过测试其与临床-放射学分级量表(CRGS)、米兰复杂性量表(MCS)和查尔森合并症指数(CCI)评分的分类一致性进行验证。结果:美国麻醉医师协会(ASA)评分、衰弱指数、颅底和后颅窝位置、直径>25 mm以及无脑肿瘤界面可预测术后早期恶化,并纳入MBSS A部分(曲线下面积[AUC]:0.965;95%置信区间[C.I.] 0.890-1.022),而衰弱指数、后颅窝位置、直径>25 mm、水肿/肿瘤体积指数>2、硬脑膜窦侵犯、扩散加权成像(DWI)高信号以及无脑肿瘤界面可预测长期不良预后,并纳入MBSS B部分(AUC:0.877;95% C.I. )。该评分与CRGS、MCS和CCI一致。结论:对患者进行多领域评估并采用衰弱指数可能有助于预测病例的围手术期复杂性、功能、临床和神经学早期预后、生存率以及术后总体生活质量。